Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917)Takahiro Nakayama, Norikazu Masuda, Masato Takahashi et al.|BMC Cancer|2021Cited by 7
Real-world effectiveness of post-T-DM1 treatments in HER2-positive metastatic breast cancer: KBCSG-TR1917 observational study.Norikazu Masuda, Takahiro Nakayama, Tetsuhiro Yoshinami et al.|Journal of Clinical Oncology|2020Cited by 0